Skip to search formSkip to main contentSkip to account menu

mesalamine

Known as: Mesalazine, m Aminosalicylic Acid, 5 asa 
An agent derived from sulfasalazine, an antiinflammatory agent. Mesalamine may reduce inflammation through inhibition of cyclooxygenase and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
s S289 Methods: Treatment of patients with extensive colitis in an advanced stage or not responder or short relapsed or… 
2003
2003
56 INTRODUCTION Inflammatory bowel disease (IBD) is a collective term for the two conditions: Crohn’s disease and ulcerative… 
1993
1993
We evaluated the efficacy, tolerance, and acceptance of a new 5-ASA colonic foam versus 5-ASA liquid enema in the short-term… 
1987
1987
A randomized clinical trial of the efficacy and safety of two different dosages of 5-aminosalicylic acid (5-ASA) enemas was… 
1987
1987
Olsalazine (ADS) is the azo-linked dimer of 5-aminosalicylic acid (5-ASA). It is of value for the management of patients with… 
1986
1986
Fifteen adult and 19 pediatric outpatients with ulcerative colitis were studied to determine the steady-state kinetics of 5… 
Highly Cited
1984
Highly Cited
1984
Enemas of 4-amino-salicylic acid (4-ASA) have been compared with placebo enemas in a double-blind study for the treatment of… 
Highly Cited
1983
Highly Cited
1983
The behaviour of a single 1-g oral dose of azodisal sodium (ADS) given to 10 healthy volunteers with an ileostomy was studied… 
1979
1979
During a normal and an accelerated intestinal transit, in seven healthy volunteers, the recoveries of salicylazosulphapyridine… 
Highly Cited
1972
Highly Cited
1972
5-Aminosalicylic acid given to rats as a single intravenous injection led to necrosis of the proximal convoluted tubules and of…